| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/24/2011 | US20110044992 Method of delivering an anti-cancer agent to a cell |
| 02/24/2011 | US20110044991 Methods and compositions for treating lymphoma and myeloma |
| 02/24/2011 | US20110044989 Zona Pellucida Binding Peptides, Expression Vectors, Compositions, and Methods for Species Specific Immunocontraception of Animals |
| 02/24/2011 | US20110044986 Anti-amyloid antibodies and uses thereof |
| 02/24/2011 | US20110044984 Monoclonal Antibody Capable of Binding to Anexelekto, and Use Thereof |
| 02/24/2011 | US20110044982 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
| 02/24/2011 | US20110044980 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 02/24/2011 | US20110044976 Humanized antibodies |
| 02/24/2011 | US20110044962 Notch induced natural killer cell generation and therapeutic uses |
| 02/24/2011 | US20110044961 Generation of Induced Pluripotent Stem Cells from Cord Blood |
| 02/24/2011 | US20110044958 Activated mesenchymal stem cells for the prevention and repair of inflammatory states |
| 02/24/2011 | US20110044957 Methods and systems for extended in vitro culture of neuronal cells |
| 02/24/2011 | US20110044954 Methods of producing germ-like cells and related therapies |
| 02/24/2011 | US20110044953 Methods and Compositions for Localized Secretion of Anti-CTLA-4 Antibodies |
| 02/24/2011 | US20110044948 Poxviral oncolytic vectors |
| 02/24/2011 | US20110044941 Immunotherapy for reversing immune suppression |
| 02/24/2011 | US20110044939 Regulatory t cells in adipose tissue |
| 02/24/2011 | US20110044902 Modulation of the Immune Response |
| 02/24/2011 | US20110044901 Novel compounds |
| 02/24/2011 | US20110044896 Tumor-targeting monoclonal antibodies to FZD10 and uses thereof |
| 02/24/2011 | US20110044895 Methods and compositions for reducing stemness in oncogenesis |
| 02/24/2011 | US20110044894 Immunoglobulin and/or Toll-Like Receptor Proteins Associated with Myelogenous Haematological Proliferative Disorders and Uses Thereof |
| 02/24/2011 | US20110044893 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 02/24/2011 | US20110044847 Method for processing tissues |
| 02/24/2011 | US20110041857 Fibroblast derived stem cells |
| 02/24/2011 | DE112008003232T5 Antigen-Bindungskonstrukte Antigen-binding constructs |
| 02/24/2011 | DE10251709C5 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3 |
| 02/24/2011 | CA2771597A1 Recombinant dna molecule encoding 5'utr capable of preventing inhibition of translation under environmental stresses |
| 02/24/2011 | CA2771591A1 Human skin explant culture system and use therefor |
| 02/24/2011 | CA2771303A1 Enhanced efficiency of induced pluripotent stem cell generation from human somatic cells |
| 02/24/2011 | CA2771261A1 Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use |
| 02/24/2011 | CA2770751A1 Process for production of bioartificial organ |
| 02/24/2011 | CA2769407A1 Mimotopes of hiv and uses thereof |
| 02/23/2011 | EP2287321A1 Multiply-substituted protease variants |
| 02/23/2011 | EP2287320A1 Multiply-substituted protease variants |
| 02/23/2011 | EP2287318A1 Mannanases |
| 02/23/2011 | EP2287316A1 Antigenic polypeptides |
| 02/23/2011 | EP2287310A1 Compositions and methods of use for mgd-csf in disease treatment |
| 02/23/2011 | EP2287309A1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 02/23/2011 | EP2287302A1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences |
| 02/23/2011 | EP2287300A1 Bacterial toxin vaccine |
| 02/23/2011 | EP2287298A1 Lipolytic enzyme variants |
| 02/23/2011 | EP2287297A1 Lipolytic enzyme variants |
| 02/23/2011 | EP2287292A2 Plant derived hydroxy phenyl pyruvate dioxygneases (HPPD) resistant against triketone herbicides and transgenic plants containing these dioxygenases |
| 02/23/2011 | EP2287291A1 Canine iPS cells and method of producing same |
| 02/23/2011 | EP2287290A2 Nestin-expressing hair follicle stem cells |
| 02/23/2011 | EP2287289A1 Seeding cells on porous supports |
| 02/23/2011 | EP2287288A1 Animal protein free media for cultivation of cells |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287199A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287198A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287194A2 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth |
| 02/23/2011 | EP2287193A1 Antibody molecules having specificity for human IL-1 beta |
| 02/23/2011 | EP2287192A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 02/23/2011 | EP2287191A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287190A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287186A1 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 02/23/2011 | EP2287185A2 High affinity TCR proteins and methods |
| 02/23/2011 | EP2287182A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2287181A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2287168A2 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 02/23/2011 | EP2286843A2 Compounds for targeting endothelial cells |
| 02/23/2011 | EP2286841A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/23/2011 | EP2286231A1 Hematopoietic cells expressing the protein susd3 and ligands for the protein susd3 |
| 02/23/2011 | EP2285409A1 Il-1 alpha abs and methods of use |
| 02/23/2011 | EP2016099B1 Method for the production of antibodies in immunodeficient animal injected with human fetal liver stem cells |
| 02/23/2011 | EP1934332B1 Methods for differentiating stem cells and use thereof in the treatment of dental conditions |
| 02/23/2011 | EP1835024B1 Method of separating pancreatic islet |
| 02/23/2011 | EP1807504B1 Serum-free cell culture medium for mammalian cells |
| 02/23/2011 | EP1801209B1 Modified human hepatitis c virus genomic rna having autonomous replicative competence |
| 02/23/2011 | EP1499720B1 Gene targeting using replicating dna molecules |
| 02/23/2011 | EP1135504B1 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 02/23/2011 | EP0972024B1 A tumor suppressor designated ts10q23.3 |
| 02/23/2011 | CN1902312B Method of constructing transgenic dendritic cell |
| 02/23/2011 | CN101981181A Method for preparation of platelet from IPS cell |
| 02/23/2011 | CN101981180A Pancreatic islet cell preparation and transplantation |
| 02/23/2011 | CN101980594A Method and apparatus for extraction of plant embryos |
| 02/23/2011 | CN101980017A Anti-TNF antibodies, compositions, methods and uses |
| 02/23/2011 | CN101979600A Method for contributing to growth of plant roots by utilizing BGIos135 genes |
| 02/23/2011 | CN101979599A Method for promoting plant roots to grow by using BGIos244 genes |
| 02/23/2011 | CN101979593A Immunotoxin, and preparation method and use thereof |
| 02/23/2011 | CN101979586A Isolated luciferases and the use thereof |
| 02/23/2011 | CN101979561A Nucleic acid molecule macrophage inflammatory protein (MIP) 3 alpha antibody to nuclear antigen (ANA) 6 and application thereof to preparation of immunosuppressive medicaments |
| 02/23/2011 | CN101979546A Promoter BgIosP574, preparation method and application thereof |
| 02/23/2011 | CN101979545A Nucleotide sequence and vector for directional cloning |
| 02/23/2011 | CN101979543A Method for cloning piricula oryzae gene of rice |
| 02/23/2011 | CN101979528A Esterase and coding gene and use thereof |
| 02/23/2011 | CN101979520A Core-binding factor alpha1 gene recombinant virus for specifically promoting cartilage differentiation, preparation method and application thereof |
| 02/23/2011 | CN101979512A Anti-porcine reproductive and respiratory syndrome virus monoclonal antibody and application |
| 02/23/2011 | CN101979511A Heavy metal zinc-resistant monoclonal antibody |
| 02/23/2011 | CN101979510A Bone marrow derived neural stem cell for expressing chemotactic factor receptor CCR5 and preparation method thereof |
| 02/23/2011 | CN101979509A Mammal cell line for stably expressing thaumatin gene and construction method |
| 02/23/2011 | CN101979508A Human blood stem cell separation material cartridge |
| 02/23/2011 | CN101979507A Sterilization method for bacterial tumor tissue holoantigen |
| 02/23/2011 | CN101979506A High-flux rice transgenic method |
| 02/23/2011 | CN101979413A Peptide purification by means of metal ion affinity chromatography |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979408A Cotton ageing related transcription factor and coded gene and application thereof |
| 02/23/2011 | CN101979407A Plant drought and salt tolerance-related protein TaCRF2 and coding gene thereof and application |
| 02/23/2011 | CN101979404A Conserved neutralizing epitope mimic peptide of H5 subtype avian influenza viruses and use thereof |